Return to all Evidence
Volume 6 | February 2025
Trip Latest Evidence Journal

Vol 6 - Feb 2025 Evidence for Primary Care

Evidence for Primary Care: the latest evidence from the Trip Database

A summary of some of the most important new documents for primary care that have recently been added to the Trip Database

Primary Care Perspectives: From Weight Loss to Gambling Woes and Epilepsy Insights

The world of primary care never stands still, and this latest collection of evidence offers a fascinating mix of challenges, from obesity management to the underrecognized impact of gambling-related harms.

The latest NICE guidelines on obesity emphasize a broad, multidisciplinary approach, blending lifestyle changes, behavioral support, and, where needed, pharmacological and surgical options. The message? There’s no one-size-fits-all solution, but rather a tailored approach that considers individual and cultural differences. With obesity at the heart of many health conditions, this evidence provides an essential roadmap for clinicians and policymakers alike.

Meanwhile, problem gambling is increasingly recognized as a serious public health issue. The new NICE guidance urges routine screening, especially among those with mental health or substance use concerns. Cognitive-behavioral therapy (CBT) remains the gold standard for treatment, but innovative digital tools and dedicated gambling support services are also being highlighted as crucial for improving access and outcomes.

Shifting to neurology, the latest epilepsy guidance reinforces the importance of prompt specialist referral after a first seizure, ensuring early and accurate diagnosis. Personalized treatment plans, careful medication management, and strong patient education are central to improving quality of life. For those with learning disabilities or transitioning from pediatric to adult care, tailored support is essential.

These updates remind us that primary care is about more than just treating symptoms—it’s about prevention, early intervention, and adapting to new evidence. Whether tackling obesity, addressing behavioral addictions, or refining epilepsy care, staying informed is key to better patient outcomes.

NICE

How should overweight and obesity be managed according to the latest NICE guidelines?

Clinical Bottom Line: The NICE guideline NG246 provides evidence-based recommendations for preventing and managing overweight and obesity across all age groups. It emphasizes a multidisciplinary approach, combining behavioral interventions, dietary and physical activity guidance, and, where appropriate, pharmacological and surgical options. The guideline highlights the need for tailored strategies, particularly for ethnic minority groups, and encourages healthcare professionals and policymakers to implement these recommendations to address obesity effectively.

Summary: This guideline outlines a comprehensive approach to obesity management, advocating for person-centered care that respects individual needs. It stresses the importance of prevention through community-wide initiatives and regular monitoring using BMI and waist circumference, with adjustments for ethnic variations. Lifestyle interventions remain the primary strategy, focusing on dietary changes, increased physical activity, and behavioral support. Pharmacological treatments and bariatric surgery are recommended when lifestyle modifications are insufficient. The role of digital tools in weight management is also acknowledged. Ensuring equitable access to care and culturally sensitive approaches is key to successful implementation.

Get more evidence: Try this Trip search for more evidence around obesity.

View Article

NICE

Addressing Gambling-Related Harms: Early Detection, Treatment, and Support

Clinical Bottom Line: The NICE guideline NG248 provides evidence-based recommendations for identifying, assessing, and managing gambling-related harms. It emphasizes routine screening by healthcare and social service professionals, particularly for individuals with mental health issues or substance use disorders. Cognitive-behavioral therapy (CBT) is the primary intervention, alongside tailored support for affected individuals and their families. The guideline also advocates for dedicated gambling treatment services, peer support, and digital tools to improve accessibility and effectiveness.

Summary: Gambling-related harms are often under-recognized, and early detection is crucial. NICE recommends that professionals routinely ask about gambling behaviors, particularly in mental health and substance use settings. CBT is the preferred treatment, adapted to individual needs, with additional support for family members. To reduce stigma and improve access, gambling services should be distinct from substance misuse services, incorporating digital and peer support options. Implementing these strategies can help mitigate the impact of problem gambling on individuals and communities.

Get more evidence: Try this Trip search for more evidence around gambling.

View Article

NICE

Comprehensive Management of Epilepsy

Clinical Bottom Line: NICE guideline NG217 provides recommendations for diagnosing and managing epilepsy in all age groups. It emphasizes prompt specialist referral after a first seizure, individualized treatment with antiseizure medications, and regular monitoring. The guideline highlights patient education, safety precautions for certain medications, and tailored support for those with learning disabilities.

Summary: Early and accurate diagnosis is key to effective epilepsy management. NICE recommends urgent referral after a first seizure and personalized treatment plans with appropriate antiseizure medications. Safety measures, especially for women of childbearing potential, are emphasized. The guideline also stresses patient education, support for caregivers, and smooth transition from pediatric to adult care. Implementing these recommendations improves seizure control and quality of life.

Search Trip: Try this Trip search for more evidence on epilepsy.

View Article

American Gastroenterological Association

What are the AGA's recommendations for noncolorectal cancer screening and vaccinations in patients with Inflammatory Bowel Disease?

Clinical Bottom Line: The AGA recommends regular noncolorectal cancer screenings and adherence to CDC vaccination guidelines for patients with IBD. These measures address increased cancer risks and ensure optimal preventive care.

Summary: Patients with IBD face higher risks for cancers beyond colorectal cancer. The AGA advises routine screenings, particularly for skin, cervical, and hepatobiliary cancers, and strict adherence to CDC vaccination schedules, especially for immunosuppressed patients. Implementing these guidelines improves long-term outcomes.

View Article

American Heart Association

How should clinicians understand and manage pain across the spectrum of peripheral artery disease?

Clinical Bottom Line: The American Heart Association’s scientific statement emphasizes that pain is a primary symptom of peripheral artery disease (PAD), ranging from intermittent claudication to critical limb ischemia. Effective management requires a comprehensive approach, including medical therapy, exercise programs, and, when necessary, revascularization procedures.

Summary: Peripheral artery disease (PAD) manifests primarily through lower extremity pain, presenting as intermittent claudication or, in severe cases, critical limb ischemia. The American Heart Association’s scientific statement highlights the importance of accurately assessing the pain experience in PAD patients to guide treatment strategies. Recommended approaches include pharmacological interventions, structured exercise regimens, and revascularization techniques when appropriate. A multidisciplinary approach is essential to address the complex pain mechanisms and improve patient outcomes in PAD.

View Article

NIHR HTA

Which combinations of index tests best predict detrusor overactivity, bladder outlet obstruction, and urodynamic stress incontinence in men in primary care?

Clinical Bottom Line: A recent study aimed to develop a clinical decision support tool for primary care to predict detrusor overactivity, bladder outlet obstruction, and urodynamic stress incontinence. The research identified combinations of index tests that effectively predict these diagnoses, potentially aiding in the management of lower urinary tract symptoms.

Summary: Lower urinary tract symptoms (LUTS) are prevalent and often challenging to diagnose accurately in primary care. This study focused on determining which combinations of index tests best predict detrusor overactivity, bladder outlet obstruction, and urodynamic stress incontinence. The findings suggest that specific test combinations can enhance diagnostic accuracy, leading to improved patient management and outcomes in primary care settings.

View Article

Ann Rheum Dis.

Is hydrocortisone replacement more effective than prednisone tapering for glucocorticoid withdrawal in rheumatoid arthritis patients with low disease activity?

Clinical Bottom Line: In patients with rheumatoid arthritis (RA) maintaining low disease activity (LDA) on a stable 5 mg/day prednisone regimen, a hydrocortisone replacement strategy did not prove superior to a gradual prednisone tapering approach for successful glucocorticoid discontinuation.

Summary: The STAR trial compared two approaches for glucocorticoid withdrawal in rheumatoid arthritis patients with stable low disease activity: hydrocortisone replacement and gradual prednisone tapering. After 12 months, both methods had similar success rates in discontinuing glucocorticoids, with no significant differences in flare rates or disease activity. No cases of acute adrenal insufficiency occurred, though some patients showed abnormal ACTH responses. The findings suggest that either strategy can be used safely for glucocorticoid withdrawal in this population.

View Article

Tools for Practice

Do gabapentinoids reduce pain in patients with fibromyalgia?

Clinical Bottom Line: Gabapentinoids, such as gabapentin and pregabalin, may provide some pain relief in fibromyalgia, but effectiveness varies, and evidence quality is low. Side effects like dizziness and weight gain are common. They can be considered as part of a personalized treatment plan but are not universally effective.

Summary: Fibromyalgia is a chronic pain condition requiring a multifaceted approach. Gabapentin and pregabalin have shown modest benefits, with pregabalin helping about one in eight patients. However, side effects are frequent, and response is inconsistent. While they may be useful for some, their role in fibromyalgia management should be individualized.

Trip search: Click here to do a search for fibromyalgia and gabapentinoids.

View Article

UK Health Security Agency

How should primary care practitioners diagnose and treat Helicobacter pylori infection in patients with dyspepsia?

Clinical Bottom Line: The UK Health Security Agency provides guidance for primary care on the diagnosis and treatment of Helicobacter pylori (H. pylori) infection in patients with dyspepsia. The recommended approach is a “test and treat” strategy, which involves testing for H. pylori and offering eradication therapy if the test is positive. This method aims to effectively manage dyspeptic symptoms and reduce the risk of peptic ulcer disease and gastric cancer.

Summary: Dyspepsia, characterized by upper abdominal discomfort, is commonly associated with H. pylori infection. The UK Health Security Agency’s guidance suggests that primary care practitioners implement a “test and treat” strategy for managing dyspepsia. This involves non-invasive testing for H. pylori, such as urea breath tests or stool antigen tests, and providing eradication therapy to those who test positive. Eradication typically includes a combination of antibiotics and proton pump inhibitors to eliminate the infection and promote mucosal healing. This approach not only alleviates dyspeptic symptoms but also decreases the likelihood of developing more serious gastrointestinal conditions.

View Article

CADTH

Is virtual mental health counselling as effective as in-person therapy for depression, anxiety, and PTSD?

Clinical Bottom Line: Virtual mental health counselling is as effective as in-person therapy for depression, anxiety, and PTSD. It is a first-line option for mild depression and a second-line or adjunct treatment for more severe cases, improving access to care.

Summary: A rapid review found virtual counselling comparable to in-person therapy for depression, generalized anxiety, social anxiety, panic disorder, and PTSD. It is recommended as a primary treatment for mild cases and as an adjunct for more severe conditions. For OCD, evidence is mixed. Virtual therapy expands access, especially in underserved areas.

View Article

British Columbia Guidelines

How should primary care practitioners in British Columbia manage tobacco use disorder?

Clinical Bottom Line: The BC guidelines recommend managing tobacco use disorder with pharmacotherapy (NRT, varenicline, bupropion) and counseling. The 5 A’s approach (Ask, Advise, Assess, Assist, Arrange) supports smoking cessation, with ongoing intervention needed due to high relapse rates. Cultural sensitivity is key for Indigenous patients.

Summary: Tobacco use disorder is a chronic condition requiring regular screening and a combination of medications and behavioral support. Pharmacotherapy and counseling together are most effective, with motivational interviewing enhancing patient engagement. Continuous follow-up is crucial, and care should be culturally appropriate, especially for Indigenous populations.

View Article

FSRH

Do GLP-1 Agonists Affect the Efficacy of Hormonal Contraception?

Clinical Bottom Line: Tirzepatide, a GLP-1 receptor agonist, has been found to significantly reduce the bioavailability of oral contraceptives, potentially decreasing their effectiveness. Other GLP-1 receptor agonists have not shown clinically relevant effects on oral contraceptive efficacy. Healthcare providers should consider alternative or additional contraceptive methods for patients using tirzepatide.

Summary: The Faculty of Sexual & Reproductive Healthcare (FSRH) has issued guidance regarding the interaction between GLP-1 receptor agonists and oral contraceptives. Notably, tirzepatide has been observed to reduce the bioavailability of oral contraceptives, which may compromise their contraceptive effectiveness. In contrast, other GLP-1 receptor agonists have not demonstrated a clinically significant impact on the pharmacokinetics of oral contraceptives. Given these findings, it is advisable for healthcare professionals to discuss alternative or supplementary contraceptive options with patients who are prescribed tirzepatide to ensure effective pregnancy prevention.

View Article

JAMA Pediatr.

What are the most effective pharmacologic treatments for managing acute pain in children?

Clinical Bottom Line: NSAIDs, ketamine, and mid- to high-potency opioids effectively reduce acute pain in children. NSAIDs are the preferred first-line option, as they also reduce the need for rescue medication without increasing short-term gastrointestinal risks.

Summary: A systematic review of 41 RCTs (4,935 children) found that NSAIDs, ketamine, and opioids significantly reduced pain. NSAIDs also decreased the need for rescue medication and had no increased risk of short-term GI side effects, making them the optimal first choice for pediatric acute pain.

Trip search: Click here to do a search for acute pain and children.

View Article

Therapeutics Letter

Should serotonergic antidepressants be prescribed to individuals with alcohol and other substance use disorders?

Clinical Bottom Line: Serotonergic antidepressants (e.g., SSRIs) are generally ineffective for treating depression in individuals with substance use disorders (SUDs) and may worsen substance use. Treatment should prioritize reducing substance use, which often improves mental health symptoms.

Summary: The Therapeutics Initiative review highlights that depression and anxiety in SUDs are often substance-related. Stopping or reducing use typically leads to symptom improvement. Antidepressants show little benefit and may be harmful, so clinicians should focus on evidence-based addiction treatments instead.

View Article

Specialist Pharmacy Service

What are the recommended treatments for hay fever during pregnancy?

Clinical Bottom Line: First-line treatment includes allergen avoidance and saline nasal irrigation. If needed, intranasal corticosteroids or ocular mast cell stabilizers are preferred due to minimal systemic absorption. Loratadine or cetirizine are the safest oral antihistamines. Decongestants should be avoided.

Summary: Hay fever in pregnancy should be managed stepwise:

  • Non-drug measures – Avoid triggers, use saline irrigation.
  • Topical treatments – Intranasal steroids (e.g., fluticasone) or mast cell stabilizers.
  • Oral antihistamines – Loratadine and cetirizine are safest; fexofenadine only if necessary.

Decongestants are not recommended. No extra fetal monitoring is usually needed.

Search Trip: Try this Trip search for more evidence on hay fever and pregnancy.

 

View Article

View Article